Goldman Sachs
IHE icon

Goldman Sachs’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Goldman Sachs’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.93M Sell
79,908
-2,970
-4% -$260K ﹤0.01% 3376
2025
Q4 		$7.03M Sell
82,878
-62,887
-43% -$5.02M ﹤0.01% 3435
2025
Q3 		$10.6M Buy
145,765
+7,287
+5% +$503K ﹤0.01% 2900
2025
Q2 		$9.08M Buy
138,478
+33,663
+32% +$2.19M ﹤0.01% 2848
2025
Q1 		$7.4M Buy
104,815
+4,815
+5% +$335K ﹤0.01% 2971
2024
Q4 		$6.57M Buy
100,000
+29,374
+42% +$2.02M ﹤0.01% 3185
2024
Q3 		$4.99M Buy
70,626
+49,829
+240% +$3.47M ﹤0.01% 3346
2024
Q2 		$1.38M Buy
20,797
+6,635
+47% +$435K ﹤0.01% 4225
2024
Q1 		$962K Sell
14,162
-26,284
-65% -$1.74M ﹤0.01% 4375
2023
Q4 		$2.5M Sell
40,446
-30,312
-43% -$1.78M ﹤0.01% 3751
2023
Q3 		$4.17M Buy
70,758
+5,463
+8% +$335K ﹤0.01% 3147
2023
Q2 		$3.9M Sell
65,295
-159
-0.2% -$9.45K ﹤0.01% 3322
2023
Q1 		$3.82M Buy
65,454
+159
+0.2% +$9.58K ﹤0.01% 3299
2022
Q4 		$4.05M Buy
65,295
+40,209
+160% +$2.42M ﹤0.01% 3359
2022
Q3 		$1.42M Sell
25,086
-63,696
-72% -$3.92M ﹤0.01% 4256
2022
Q2 		$5.67M Buy
88,782
+63,825
+256% +$4.05M ﹤0.01% 3018
2022
Q1 		$1.62M Buy
+24,957
New +$1.58M ﹤0.01% 4422
2021
Q4 		– Sell
-9,108
Closed -$556K – 6563
2021
Q3 		$556K Hold
9,108
– – ﹤0.01% 5135
2021
Q2 		$564K Buy
9,108
+2,946
+48% +$179K ﹤0.01% 5144
2021
Q1 		$365K Buy
6,162
+162
+3% +$9.77K ﹤0.01% 5318
2020
Q4 		$359K Hold
6,000
– – ﹤0.01% 4800
2020
Q3 		$327K Sell
6,000
-10,014
-63% -$540K ﹤0.01% 4687
2020
Q2 		$821K Buy
16,014
+9,000
+128% +$452K ﹤0.01% 4089
2020
Q1 		$315K Sell
7,014
-300,000
-98% -$15.1M ﹤0.01% 4469
2019
Q4 		$16.4M Sell
307,014
-1,350,000
-81% -$66.5M ﹤0.01% 2033
2019
Q3 		$77.2M Buy
1,657,014
+1,200,000
+263% +$57.5M 0.02% 815
2019
Q2 		$23M Buy
457,014
+450,000
+6,416% +$22.2M 0.01% 1736
2019
Q1 		$360K Buy
+7,014
New +$349K ﹤0.01% 4557
2018
Q3 		– Sell
-13,839
Closed -$698K – 5676
2018
Q2 		$698K Hold
13,839
– – ﹤0.01% 4306
2018
Q1 		$681K Hold
13,839
– – ﹤0.01% 4291
2017
Q4 		$712K Sell
13,839
-3,039
-18% -$156K ﹤0.01% 4557
2017
Q3 		$880K Sell
16,878
-150,000
-90% -$7.7M ﹤0.01% 4688
2017
Q2 		$8.63M Sell
166,878
-2,322
-1% -$117K ﹤0.01% 2625
2017
Q1 		$8.51M Sell
169,200
-2,946
-2% -$146K ﹤0.01% 2528
2016
Q4 		$8.12M Buy
172,146
+20,814
+14% +$988K ﹤0.01% 2625
2016
Q3 		$7.54M Sell
151,332
-150,558
-50% -$7.64M ﹤0.01% 2683
2016
Q2 		$14.5M Buy
301,890
+207
+0.1% +$9.85K ﹤0.01% 2035
2016
Q1 		$13.8M Sell
301,683
-448,740
-60% -$21M ﹤0.01% 1992
2015
Q4 		$40.4M Buy
750,423
+599,472
+397% +$31.5M 0.01% 1275
2015
Q3 		$7.45M Sell
150,951
-3,795
-2% -$218K ﹤0.01% 2512
2015
Q2 		$9.02M Buy
154,746
+4,002
+3% +$234K ﹤0.01% 2417
2015
Q1 		$8.66M Sell
150,744
-2,538
-2% -$139K ﹤0.01% 2416
2014
Q4 		$7.74M Buy
153,282
+33,267
+28% +$1.62M ﹤0.01% 2571
2014
Q3 		$5.62M Sell
120,015
-6,762
-5% -$305K ﹤0.01% 2897
2014
Q2 		$5.71M Buy
126,777
+45,885
+57% +$1.97M ﹤0.01% 2895
2014
Q1 		$3.42M Buy
80,892
+44,916
+125% +$1.88M ﹤0.01% 3455
2013
Q4 		$1.42M Buy
35,976
+24,564
+215% +$922K ﹤0.01% 4423
2013
Q3 		$405K Buy
+11,412
New +$402K ﹤0.01% 5323

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Goldman Sachs's IHE Position: Q1 2026 in Review

Goldman Sachs reduced its iShares US Pharmaceuticals ETF (IHE) stake by 3.6% in Q1 2026, selling an estimated $260K and leaving 79,908 shares worth $6.93M. The position accounts for ﹤0.01% of the portfolio, ranked #3376.

Goldman Sachs first reported a position in IHE in Q3 2013 and has held it in 48 quarters since. The position peaked at $77.2M in Q3 2019. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

  • Goldman Sachs held 79,908 shares of iShares US Pharmaceuticals ETF worth $6.93M as of Q1 2026.
  • Goldman Sachs sold 2,970 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $260K.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3376 holding.
  • Goldman Sachs first reported a position in iShares US Pharmaceuticals ETF in Q3 2013 and has held it in 48 quarters since.
  • Goldman Sachs's iShares US Pharmaceuticals ETF position peaked at $77.2M in Q3 2019.
  • 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.